Join
Live feed
·
PRReleasevia Quantisnow
Palatin Technologies Inc. logo

Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025

ByQuantisnow·Wall Street's wire, on your screen.
PTN· Palatin Technologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PTN (Palatin Technologies Inc.) and more on Quantisnow.